Serotonergic mediated body mass index changes in Parkinson's disease

Neurobiology of Disease

Volumn 43, Issue 3, 2011, Pages 609-615

  Politis, Marios ^a   Loane, Clare ^a   Wu, Kit ^a   Brooks, David J ^a   Piccini, Paola ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

BMI; DASB; Parkinson's disease Parkinsonism; PET; Serotonin

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; SEROTONIN; SEROTONIN TRANSPORTER;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; BODY MASS; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HYPOTHALAMUS; IN VIVO STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RAPHE NUCLEUS; SEROTONINERGIC SYSTEM; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

AGED; APPETITE; BENZYLAMINES; BODY MASS INDEX; BRAIN; CARBON RADIOISOTOPES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 79960250055     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.05.009     Document Type: Article

References (44)

1. Abbott R.A., Cox M., Markus H., Tomkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur. J. Clin. Nutr. 1992, 46:879-884.
2. Adams K.H., Pinborg L.H., Svarer C., et al. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. NeuroImage 2004, 21:1105-1113.
3. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
4. Bever K.A., Perry P.J. Dexfenfluramine hydrochloride: an anorexigenic agent. Am. J. Health Syst. Pharm 1997, 54:2059-2072.
5. Beyer P.L., Palarino M.Y., Michalek D., Busenbark K., Koller W.C. Weight change and body composition in patients with Parkinson's disease. J. Am. Diet. Assoc. 1995, 95:979-983.
6. Bragulat V., Dzemidzic M., Bruno C., et al. Food-related odor probes of brain reward circuits during hunger: a pilot FMRI study. Obesity 2010, 18:1566-1571.
7. Breisch S.T., Zemlan F.P., Hoebel B.G. Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine. Science 1976, 192:382-385.
8. Carlini V.P., Varas M.M., Cragnolini A.B., Schiöth H.B., Scimonelli T.N., de Barioglio S.R. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem. Biophys. Res. Commun. 2004, 313:635-641.
9. Chaudhuri K.R., Healy D.G. National Institute for Clinical Excellence. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006, 5:235-245.
10. Chen H., Zhang S.M., Hernán M.A., Willett W.C., Ascherio A. Weight loss in Parkinson's disease. Ann. Neurol. 2003, 53:676-679.
11. Conrad L.C., Leonard C.M., Pfaff D.W. Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study. J. Comp. Neurol. 1974, 156:179-205.
12. De Araujo I.E., Rolls E.T. Representation in the human brain of food texture and oral fat. J. Neurosci. 2004, 24:3086-3093.
13. Duvernoy H.M. The Human Brain: Surface, Blood Supply, and Three-dimensional Sectional Anatomy 1999, Springer-Verlag Wien, New York. 2nd ed.
14. Erritzoe D., Frokjaer V.G., Haugbol S., et al. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. NeuroImage 2009, 46:23-30.
15. Erritzoe D., Frokjaer V.G., Haahr M.T., et al. Cerebral serotonin transporter binding is inversely related to body mass index. NeuroImage 2010, 52:284-289.
16. Gasparini M., Spinnler H. Fattening of parkinsonians: a hypothalamic side effect of L-dopa?. Med. J. Aust. 1975, 2:617.
17. Ginovart N., Wilson A.A., Meyer J.H., Hussey D., Houle S. Positron emission tomography quantification of [(11)C]-DASB binding to the human serotonin transporter: modeling strategies. J. Cereb. Blood Flow Metab. 2001, 21:1342-1353.
18. Goldstone A.P., de Hernandez C.G., Beaver J.D., et al. Fasting biases brain reward systems towards high-calorie foods. Eur. J. Neurosci. 2009, 30:1625-1635.
19. Goto Y., Grace A.A. Limbic and cortical information processing in the nucleus accumbens. Trends Neurosci. 2008, 31:552-558.
20. Grabenhorst F., Rolls E.T., Parris B.A., d'Souza A.A. How the brain represents the reward value of fat in the mouth. Cereb Cortex 2010, 20:1082-1091.
21. Grahn J.A., Parkinson J.A., Owen A.M. The cognitive functions of the caudate nucleus. Prog. Neurobiol. 2008, 86:141-155.
22. Kelley A.E., Baldo B.A., Pratt W.E., Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol. Behav. 2005, 86:773-795.
23. Kish S.J., Furukawa Y., Chang L.J., et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?. Nucl. Med. Biol. 2005, 32:123-128.
24. Kish S.J., Tong J., Hornykiewicz O., et al. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain 2008, 131:120-131.
25. Leibowitz S.F., Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry 1998, 44:851-864.
26. Lesch K.P., Gutknecht L. Pharmacogenetics of the serotonin transporter. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:1062-1073.
27. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
28. Macia F., Perlemoine C., Coman I., et al. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov. Disord. 2004, 19:206-212.
29. Martin L.E., Holsen L.M., Chambers R.J., et al. Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity 2010, 18:254-260.
30. Matsumoto R., Ito H., Takahashi H., Suhara T. Inverse correlation between body mass index and serotonin transporter binding in human brain: a [11C-DASB] PET study. NeuroImage 2008, 41:T161.
31. McDonald W.M., Richard I.H., DeLong M.R. Prevalence, etiology, and treatment of depression in Parkinson's disease. Biol. Psychiatry 2003, 54:363-375.
32. Montgomery A.J., Thielemans K., Mehta M.A., Turkheimer F., Mustafovic S., Grasby P.M. Correction of head movement on PET studies: comparison of methods. J. Nucl. Med. 2006, 47:1936-1944.
33. Moroo I., Yamada T., Hirayama K. Body weight loss in patients with Parkinson's disease. Neurol. Med. 1994, 41:65-67.
34. Morris B.J., Reimer S., Höllt V., Herz A. Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Brain Res. 1988, 464:15-22.
35. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
36. Ondo W.G., Ben-Aire L., Jankovic J., Lai E., Contant C., Grossman R. Weight gain following unilateral pallidotomy in Parkinson's disease. Acta Neurol. Scand. 2000, 101:79-84.
37. Politis M., Wu K., Loane C., et al. Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study. Neurobiol. Dis. 2010, 40:216-221.
38. Postuma R.B., Dagher A. Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications. Cereb. Cortex 2006, 16:1508-1521.
39. Rothemund Y., Preuschhof C., Bohner G., et al. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. NeuroImage 2007, 37:410-421.
40. Saller C.F., Stricker E.M. Gastrointestinal motility and body weight gain in rats after brain serotonin depletion by 5, 7-dihydroxytryptamine. Neuropharmacology 1978, 17:499-506.
41. Scatton B., Javoy-Agid F., Rouquier L., Dubois B., Agid Y. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res. 1983, 275:321-328.
42. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
43. Shannak K., Rajput A., Rozdilsky B., Kish S., Gilbert J., Hornykiewicz O. Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects. Brain Res. 1994, 639:33-41.
44. Weltzin T.E., Fernstrom M.H., Fernstrom J.D., Neuberger S.K., Kaye W.H. Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am. J. Psychiatry 1995, 152:1668-1671.